Volgende

Automatisch afspelen

HER2+ Inflammatory Breast Cancer: Neoadjuvant Approaches

0 Bekeken • 07/03/23
Delen
insluiten
administrator
administrator
abonnees
0

Debu Tripathy, MD, shares insight on the optimal neoadjuvant approaches to HER2+ inflammatory breast cancer with regard to the availability of hormonal and chemotherapeutic agents.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

Laat meer zien
0 Comments sort Sorteer op
Facebook Reacties

Volgende

Automatisch afspelen